Literature DB >> 19086352

Direct cost of ambulatory care of type 2 diabetes in the middle and high income group populace of Delhi: the DEDICOM survey.

A Kumar1, J Nagpal, A Bhartia.   

Abstract

OBJECTIVE: To estimate the direct cost of ambulatory care in diabetes patients in the middle and high income group populace of Delhi. RESEARCH DESIGN AND METHODS: We analyzed the drugs, investigations, consultation and monitoring related data available from a survey of 35- 65-year-old known diabetes patients conducted using a probability-proportionate-to-size 2-stage cluster design to calculate the direct cost of ambulatory diabetes care.
RESULTS: A total of 819 subjects were enrolled from 20,666 houses. The average estimate of direct annual expenditure on ambulatory care of diabetes was approximately Rs. 6000 (approximately US$ 150). Time elapsed since diagnosis (p<0.001), education (p=0.011), gross family income (p=0.002), presence of co-morbidities (p=0.009) and requirement for useof oral hypoglycemic agents (p<0.001) or insulin (p<0.001) were significant correlates. Direct ambulatory cost of care comprised 1-3% of the gross family income of the subjects.
CONCLUSION: Despite the limitations of the present study it may be concluded that a majority of the diabetes patients spend a significant proportion of their family income on diabetes related expenditure. The cost is higher for subjects with longer duration since diagnosis, those with higher education or income, those with co-morbidities and those requiring oral hypoglycemic agents or insulin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19086352

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  11 in total

Review 1.  Prevalence of type 2 diabetes and its complications in India and economic costs to the nation.

Authors:  R Pradeepa; V Mohan
Journal:  Eur J Clin Nutr       Date:  2017-04-19       Impact factor: 4.016

Review 2.  Economic Impact of Diabetes in South Asia: the Magnitude of the Problem.

Authors:  Kavita Singh; K M Venkat Narayan; Karen Eggleston
Journal:  Curr Diab Rep       Date:  2019-05-16       Impact factor: 4.810

Review 3.  Remogliflozin: the new low cost SGLT-2 inhibitor for type 2 diabetes mellitus.

Authors:  Shubham Atal; Zeenat Fatima; Sakshi Singh; Sadasivam Balakrishnan; Rajnish Joshi
Journal:  Diabetol Int       Date:  2020-10-29

Review 4.  The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.

Authors:  Taulant Muka; David Imo; Loes Jaspers; Veronica Colpani; Layal Chaker; Sven J van der Lee; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Abby Falla; Raha Pazoki; Oscar H Franco
Journal:  Eur J Epidemiol       Date:  2015-01-18       Impact factor: 8.082

5.  Economic burden of diabetes in urban indians.

Authors:  Pablo Chandra; Bageshri Gogate; Parikshit Gogate; Nilesh Thite; Abhay Mutha; Amit Walimbe
Journal:  Open Ophthalmol J       Date:  2014-12-31

Review 6.  The economic burden of diabetes in India: a review of the literature.

Authors:  Charles A K Yesudian; Mari Grepstad; Erica Visintin; Alessandra Ferrario
Journal:  Global Health       Date:  2014-12-02       Impact factor: 4.185

Review 7.  Economic menace of diabetes in India: a systematic review.

Authors:  Sumit Oberoi; Pooja Kansra
Journal:  Int J Diabetes Dev Ctries       Date:  2020-06-17

Review 8.  Emotional and Psychological Needs of People with Diabetes.

Authors:  Sanjay Kalra; Biranchi Narayan Jena; Rajiv Yeravdekar
Journal:  Indian J Endocrinol Metab       Date:  2018 Sep-Oct

9.  Drug Prescription Patterns and Cost Analysis of Diabetes Therapy in India: Audit of an Endocrine Practice.

Authors:  Rajiv Singla; Jatin Bindra; Ankush Singla; Yashdeep Gupta; Sanjay Kalra
Journal:  Indian J Endocrinol Metab       Date:  2019 Jan-Feb

10.  National recommendations: Psychosocial management of diabetes in India.

Authors:  Sanjay Kalra; G R Sridhar; Yatan Pal Singh Balhara; Rakesh Kumar Sahay; Ganapathy Bantwal; Manash P Baruah; Mathew John; Ambika Gopalkrishnan Unnikrishnan; K Madhu; Komal Verma; Aswathy Sreedevi; Rishi Shukla; K M Prasanna Kumar
Journal:  Indian J Endocrinol Metab       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.